Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression

NCT07737990 is registered in ClinicalTrials.gov with Joshua Rosenblat as lead sponsor.

NCT NCT07737990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07737990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression
Lead sponsor
Joshua Rosenblat
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
July 1, 2026
Completion date
June 30, 2030
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment-resistant depression (trd)